A CIBMTR Prognostic Model for Progression-Free Survival (PFS) After Autologous Hematopoietic Cell Transplantation (AHCT) for Relapsed or Refractory Hodgkin Lymphoma (HL)

被引：0
|
作者：
Hahn, Theresa [1 ]
McCarthy, Philip L., Jr. [1 ]
Carreras, Jeanette [2 ]
Zhang, Mei-Jie
Lazarus, Hillard M. [3 ]
Laport, Ginna G. [4 ]
Montoto, Silvia [5 ]
Maloney, David G. [6 ]
Hari, Parameswaran [2 ]
机构：
[1] Roswell Pk Canc Inst, Med BMT Program, Buffalo, NY 14263 USA
[2] Med Coll Wisconsin, CIBMTR, Milwaukee, WI 53226 USA
[3] Univ Hosp Case Med Ctr, Cleveland, OH USA
[4] Stanford Univ, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA
[5] QMUL, Barts Canc Inst, Ctr Haematol Oncol, London, England
[6] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：232 / 233
页数：2
相关论文
共 50 条
  • [31] A Cure Rate Survival Model after Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma Patients
    Mohseni, Navid
    Maboudi, Ali Akbar Khadem
    Baghestani, Ahmadreza
    Hajifathali, Abbas
    Saeedi, Anahita
    MIDDLE EAST JOURNAL OF CANCER, 2022, 13 (03) : 427 - 437
  • [32] Allogeneic stem cell transplantation (AlloSCT) for relapsed Hodgkin's lymphoma (HL) following autologous stem cell transplantation (AuSCT): Improved progression-free survival (PFS) in patients with graft vs host-disease (GvHD) suggests a graft vs lymphoma (GVL) effect.
    Altman, JK
    Gordon, LI
    Monreal, J
    Evens, AM
    Williams, SF
    Tallman, MS
    Singhal, S
    Mehta, J
    Winter, JN
    BLOOD, 2005, 106 (11) : 450B - 451B
  • [33] Outcomes in patients with relapsed/refractory Hodgkin lymphoma (RR-HL) with progression after autologous stem cell transplantation in the current era of novel therapeutics.
    Bair, Steven Michael
    Strelec, Lauren E.
    Nasta, Sunita
    Mato, Anthony R.
    Landsburg, Daniel Jeffrey
    Stadtmauer, Edward Allen
    Loren, Alison W.
    Schuster, Stephen J.
    Svoboda, Jakub
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin’s lymphoma in patients older than 50 years
    C. Martínez
    A. S. Jorge
    A. Pereira
    M. Moreno
    J. Núñez
    J. Gayoso
    J. Gonzalez-Medina
    N. Revilla
    A. Sampol
    E. Domingo-Domenech
    F. de la Cruz
    A. Morales
    M. J. Rodriguez-Salazar
    S. Valiente
    E. Pérez-Ceballos
    J. Pérez de Oteyza
    R. García-Sanz
    Annals of Hematology, 2017, 96 : 9 - 16
  • [35] Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin's lymphoma in patients older than 50 years
    Martinez, C.
    Jorge, A. S.
    Pereira, A.
    Moreno, M.
    Nunez, J.
    Gayoso, J.
    Gonzalez-Medina, J.
    Revilla, N.
    Sampol, A.
    Domingo-Domenech, E.
    de la Cruz, F.
    Morales, A.
    Rodriguez-Salazar, M. J.
    Valiente, S.
    Perez-Ceballos, E.
    Perez de Oteyza, J.
    Garcia-Sanz, R.
    ANNALS OF HEMATOLOGY, 2017, 96 (01) : 9 - 16
  • [36] A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease
    Hahn, T
    Benekli, M
    Wong, C
    Moysich, KB
    Hyland, A
    Michalek, AM
    Alam, A
    Baer, MR
    Bambach, B
    Czuczman, MS
    Wetzler, M
    Becker, JL
    McCarthy, PL
    BONE MARROW TRANSPLANTATION, 2005, 35 (06) : 557 - 566
  • [37] A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease
    S Tey
    J Butler
    S Durrant
    G Hill
    J Morton
    G Kennedy
    Bone Marrow Transplantation, 2005, 36 : 553 - 554
  • [38] A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease
    Tey, S
    Butler, J
    Durrant, S
    Durrant, S
    Hill, G
    Morton, J
    Kennedy, G
    BONE MARROW TRANSPLANTATION, 2005, 36 (06) : 553 - 554
  • [39] A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease
    T Hahn
    M Benekli
    C Wong
    K B Moysich
    A Hyland
    A M Michalek
    A Alam
    M R Baer
    B Bambach
    M S Czuczman
    M Wetzler
    J L Becker
    P L McCarthy
    Bone Marrow Transplantation, 2005, 35 : 557 - 566
  • [40] Progression-free survival at 24 months as a landmark after autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma.
    Tun, Aung M.
    Maliske, Seth
    Wang, Yucai
    Maurer, Matthew J.
    Micallef, Ivana N. M.
    Inwards, David James
    Porrata, Luis F.
    Rosenthal, Allison Claire
    Kharfan-Dabaja, Mohamed
    Orme, Jacob
    Link, Brian K.
    Cerhan, James Robert
    Thompson, Carrie A.
    Habermann, Thomas Matthew
    Witzig, Thomas E.
    Ansell, Stephen M.
    Nowakowski, Grzegorz S.
    Farooq, Umar
    Johnston, Patrick B.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345